EDGAR Filing Documents for 0001193125-18-130838

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:

SEC Accession No. 0001193125-18-130838

Filing Date

2018-04-25

Accepted

2018-04-25 13:04:55

Documents

Effectiveness Date

2018-04-25

Document Format Files

Seq	Description	Document	Type	Size
1	DEFA14A	d554289ddefa14a.htm	DEFA14A	53482
2	GRAPHIC	g5542890001.jpg	GRAPHIC	5340
3	GRAPHIC	g5542891.jpg	GRAPHIC	100031
4	GRAPHIC	g5542892.jpg	GRAPHIC	181941
5	GRAPHIC	g5542893.jpg	GRAPHIC	62430
6	GRAPHIC	g5542894.jpg	GRAPHIC	22342
7	GRAPHIC	g554289com.jpg	GRAPHIC	1922
8	GRAPHIC	g554289let.jpg	GRAPHIC	1404
9	GRAPHIC	g554289phn.jpg	GRAPHIC	1905
	Complete submission text file	0001193125-18-130838.txt		569866

Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131

Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267

TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)